^

Association details:

Evidence:

Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:
627. Preclinical Evaluation of B7-H3-Targeted CAR-T Cells against Triple Negative Breast Cancer
Published date:
04/27/2021
Excerpt:
B7-H3-targeted CAR-T cells showed significant in vivo anti-tumor activity in orthotopic xenograft...B7-H3 is overexpressed in several TNBC cell lines and B7-H3-targeted CAR-T cells preferentially attack tumor cells with high B7-H3 expression.
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our